The global market for Formulation Development Services was valued at US$ 9365 million in the year 2024 and is projected to reach a revised size of US$ 14570 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Formula development service refers to a professional service that customizes and optimizes product formulas for customers through scientific research and experiments. It covers the entire process from raw material selection, ingredient ratio adjustment to production process optimization, aiming to meet customers' specific needs for product function, performance, safety and cost. Formula development services are widely used in many industries such as cosmetics, food, pharmaceuticals, cleaning products, chemical products, etc., helping customers develop innovative products with market competitiveness. Through professional formula development services, companies can improve product quality, reduce production costs, and respond quickly to market demand.
North American market for Formulation Development Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Formulation Development Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Formulation Development Services in Large Enterprises is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Formulation Development Services include Coriolis Pharma, Aurigene Pharmaceutical Services, Adragos Pharma, Ascendia Pharmaceuticals, Dalton Pharma Services, Intertek, Suven Pharma, Agno Pharma, SGS SA, DPT Laboratories Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Formulation Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Formulation Development Services.
The Formulation Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Formulation Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Formulation Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Coriolis Pharma
Aurigene Pharmaceutical Services
Adragos Pharma
Ascendia Pharmaceuticals
Dalton Pharma Services
Intertek
Suven Pharma
Agno Pharma
SGS SA
DPT Laboratories Ltd
MedPharm
Octavius Pharma
Pharmaron
CuriRx, Inc.
LGM pharma
Avivia BV
Corealis
Losan Pharma
Evonik Health Care
Lonza
Alcami
Scantox
Segment by Type
Food and Beverage Formula Development
Drug Formula Development
Cosmetic Formula Development
Health Care Product Formula Development
Others
Segment by Application
Large Enterprises
Small and Medium Enterprises
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Formulation Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Formulation Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Food and Beverage Formula Development
1.2.3 Drug Formula Development
1.2.4 Cosmetic Formula Development
1.2.5 Health Care Product Formula Development
1.2.6 Others
1.3 Market by Application
1.3.1 Global Formulation Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Large Enterprises
1.3.3 Small and Medium Enterprises
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Formulation Development Services Market Perspective (2020-2031)
2.2 Global Formulation Development Services Growth Trends by Region
2.2.1 Global Formulation Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Formulation Development Services Historic Market Size by Region (2020-2025)
2.2.3 Formulation Development Services Forecasted Market Size by Region (2026-2031)
2.3 Formulation Development Services Market Dynamics
2.3.1 Formulation Development Services Industry Trends
2.3.2 Formulation Development Services Market Drivers
2.3.3 Formulation Development Services Market Challenges
2.3.4 Formulation Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Formulation Development Services Players by Revenue
3.1.1 Global Top Formulation Development Services Players by Revenue (2020-2025)
3.1.2 Global Formulation Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Formulation Development Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Formulation Development Services Revenue
3.4 Global Formulation Development Services Market Concentration Ratio
3.4.1 Global Formulation Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Formulation Development Services Revenue in 2024
3.5 Global Key Players of Formulation Development Services Head office and Area Served
3.6 Global Key Players of Formulation Development Services, Product and Application
3.7 Global Key Players of Formulation Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Formulation Development Services Breakdown Data by Type
4.1 Global Formulation Development Services Historic Market Size by Type (2020-2025)
4.2 Global Formulation Development Services Forecasted Market Size by Type (2026-2031)
5 Formulation Development Services Breakdown Data by Application
5.1 Global Formulation Development Services Historic Market Size by Application (2020-2025)
5.2 Global Formulation Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Formulation Development Services Market Size (2020-2031)
6.2 North America Formulation Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Formulation Development Services Market Size by Country (2020-2025)
6.4 North America Formulation Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Formulation Development Services Market Size (2020-2031)
7.2 Europe Formulation Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Formulation Development Services Market Size by Country (2020-2025)
7.4 Europe Formulation Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Formulation Development Services Market Size (2020-2031)
8.2 Asia-Pacific Formulation Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Formulation Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Formulation Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Formulation Development Services Market Size (2020-2031)
9.2 Latin America Formulation Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Formulation Development Services Market Size by Country (2020-2025)
9.4 Latin America Formulation Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Formulation Development Services Market Size (2020-2031)
10.2 Middle East & Africa Formulation Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Formulation Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Formulation Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Coriolis Pharma
11.1.1 Coriolis Pharma Company Details
11.1.2 Coriolis Pharma Business Overview
11.1.3 Coriolis Pharma Formulation Development Services Introduction
11.1.4 Coriolis Pharma Revenue in Formulation Development Services Business (2020-2025)
11.1.5 Coriolis Pharma Recent Development
11.2 Aurigene Pharmaceutical Services
11.2.1 Aurigene Pharmaceutical Services Company Details
11.2.2 Aurigene Pharmaceutical Services Business Overview
11.2.3 Aurigene Pharmaceutical Services Formulation Development Services Introduction
11.2.4 Aurigene Pharmaceutical Services Revenue in Formulation Development Services Business (2020-2025)
11.2.5 Aurigene Pharmaceutical Services Recent Development
11.3 Adragos Pharma
11.3.1 Adragos Pharma Company Details
11.3.2 Adragos Pharma Business Overview
11.3.3 Adragos Pharma Formulation Development Services Introduction
11.3.4 Adragos Pharma Revenue in Formulation Development Services Business (2020-2025)
11.3.5 Adragos Pharma Recent Development
11.4 Ascendia Pharmaceuticals
11.4.1 Ascendia Pharmaceuticals Company Details
11.4.2 Ascendia Pharmaceuticals Business Overview
11.4.3 Ascendia Pharmaceuticals Formulation Development Services Introduction
11.4.4 Ascendia Pharmaceuticals Revenue in Formulation Development Services Business (2020-2025)
11.4.5 Ascendia Pharmaceuticals Recent Development
11.5 Dalton Pharma Services
11.5.1 Dalton Pharma Services Company Details
11.5.2 Dalton Pharma Services Business Overview
11.5.3 Dalton Pharma Services Formulation Development Services Introduction
11.5.4 Dalton Pharma Services Revenue in Formulation Development Services Business (2020-2025)
11.5.5 Dalton Pharma Services Recent Development
11.6 Intertek
11.6.1 Intertek Company Details
11.6.2 Intertek Business Overview
11.6.3 Intertek Formulation Development Services Introduction
11.6.4 Intertek Revenue in Formulation Development Services Business (2020-2025)
11.6.5 Intertek Recent Development
11.7 Suven Pharma
11.7.1 Suven Pharma Company Details
11.7.2 Suven Pharma Business Overview
11.7.3 Suven Pharma Formulation Development Services Introduction
11.7.4 Suven Pharma Revenue in Formulation Development Services Business (2020-2025)
11.7.5 Suven Pharma Recent Development
11.8 Agno Pharma
11.8.1 Agno Pharma Company Details
11.8.2 Agno Pharma Business Overview
11.8.3 Agno Pharma Formulation Development Services Introduction
11.8.4 Agno Pharma Revenue in Formulation Development Services Business (2020-2025)
11.8.5 Agno Pharma Recent Development
11.9 SGS SA
11.9.1 SGS SA Company Details
11.9.2 SGS SA Business Overview
11.9.3 SGS SA Formulation Development Services Introduction
11.9.4 SGS SA Revenue in Formulation Development Services Business (2020-2025)
11.9.5 SGS SA Recent Development
11.10 DPT Laboratories Ltd
11.10.1 DPT Laboratories Ltd Company Details
11.10.2 DPT Laboratories Ltd Business Overview
11.10.3 DPT Laboratories Ltd Formulation Development Services Introduction
11.10.4 DPT Laboratories Ltd Revenue in Formulation Development Services Business (2020-2025)
11.10.5 DPT Laboratories Ltd Recent Development
11.11 MedPharm
11.11.1 MedPharm Company Details
11.11.2 MedPharm Business Overview
11.11.3 MedPharm Formulation Development Services Introduction
11.11.4 MedPharm Revenue in Formulation Development Services Business (2020-2025)
11.11.5 MedPharm Recent Development
11.12 Octavius Pharma
11.12.1 Octavius Pharma Company Details
11.12.2 Octavius Pharma Business Overview
11.12.3 Octavius Pharma Formulation Development Services Introduction
11.12.4 Octavius Pharma Revenue in Formulation Development Services Business (2020-2025)
11.12.5 Octavius Pharma Recent Development
11.13 Pharmaron
11.13.1 Pharmaron Company Details
11.13.2 Pharmaron Business Overview
11.13.3 Pharmaron Formulation Development Services Introduction
11.13.4 Pharmaron Revenue in Formulation Development Services Business (2020-2025)
11.13.5 Pharmaron Recent Development
11.14 CuriRx, Inc.
11.14.1 CuriRx, Inc. Company Details
11.14.2 CuriRx, Inc. Business Overview
11.14.3 CuriRx, Inc. Formulation Development Services Introduction
11.14.4 CuriRx, Inc. Revenue in Formulation Development Services Business (2020-2025)
11.14.5 CuriRx, Inc. Recent Development
11.15 LGM pharma
11.15.1 LGM pharma Company Details
11.15.2 LGM pharma Business Overview
11.15.3 LGM pharma Formulation Development Services Introduction
11.15.4 LGM pharma Revenue in Formulation Development Services Business (2020-2025)
11.15.5 LGM pharma Recent Development
11.16 Avivia BV
11.16.1 Avivia BV Company Details
11.16.2 Avivia BV Business Overview
11.16.3 Avivia BV Formulation Development Services Introduction
11.16.4 Avivia BV Revenue in Formulation Development Services Business (2020-2025)
11.16.5 Avivia BV Recent Development
11.17 Corealis
11.17.1 Corealis Company Details
11.17.2 Corealis Business Overview
11.17.3 Corealis Formulation Development Services Introduction
11.17.4 Corealis Revenue in Formulation Development Services Business (2020-2025)
11.17.5 Corealis Recent Development
11.18 Losan Pharma
11.18.1 Losan Pharma Company Details
11.18.2 Losan Pharma Business Overview
11.18.3 Losan Pharma Formulation Development Services Introduction
11.18.4 Losan Pharma Revenue in Formulation Development Services Business (2020-2025)
11.18.5 Losan Pharma Recent Development
11.19 Evonik Health Care
11.19.1 Evonik Health Care Company Details
11.19.2 Evonik Health Care Business Overview
11.19.3 Evonik Health Care Formulation Development Services Introduction
11.19.4 Evonik Health Care Revenue in Formulation Development Services Business (2020-2025)
11.19.5 Evonik Health Care Recent Development
11.20 Lonza
11.20.1 Lonza Company Details
11.20.2 Lonza Business Overview
11.20.3 Lonza Formulation Development Services Introduction
11.20.4 Lonza Revenue in Formulation Development Services Business (2020-2025)
11.20.5 Lonza Recent Development
11.21 Alcami
11.21.1 Alcami Company Details
11.21.2 Alcami Business Overview
11.21.3 Alcami Formulation Development Services Introduction
11.21.4 Alcami Revenue in Formulation Development Services Business (2020-2025)
11.21.5 Alcami Recent Development
11.22 Scantox
11.22.1 Scantox Company Details
11.22.2 Scantox Business Overview
11.22.3 Scantox Formulation Development Services Introduction
11.22.4 Scantox Revenue in Formulation Development Services Business (2020-2025)
11.22.5 Scantox Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Coriolis Pharma
Aurigene Pharmaceutical Services
Adragos Pharma
Ascendia Pharmaceuticals
Dalton Pharma Services
Intertek
Suven Pharma
Agno Pharma
SGS SA
DPT Laboratories Ltd
MedPharm
Octavius Pharma
Pharmaron
CuriRx, Inc.
LGM pharma
Avivia BV
Corealis
Losan Pharma
Evonik Health Care
Lonza
Alcami
Scantox
听
听
*If Applicable.
